April 2024

Marketing Material

Innovation

The AtonRâ Innovation is a long-only, USD-based actively-managed certificate.
From July the 7th 2020 onwards, AtonRâ Innovation invests exclusively its proceeds in the "The AtonRâ Fund" Z-class (no fees).
The AtonRâ Fund invests in long-only listed equities benefiting from secular growth opportunities over a medium to long-term time horizon, with a focus on the technology, healthcare, and renewable energy sectors.
Through one single product, investors gather exposure to the company’s core growth themes which are managed individually since 2014.
The Fund builds on AtonRâ Partners’ unique research and investment approach, which draws scientific, technological, and industrial research together with quality-oriented financial analysis.

Main Features
Asset Class Equity
Legal Structure Actively Managed Certificate
Investment Index Long
Launch date 23-Jul-15
Currency USD
Type of Return Total return
Ticker NXSRATRA
isin XS0884325415
Issuer Natixis
Issue Price 100
Last Price 162.14
Sharpe Ratio 0.24
Correlation 0.76
Beta 1.31
Reference Index MSCI ACWI Net TR (USD)
Liquidity Daily
# Holdings 198
Management Fees 1.30%
Issuer Fees 0.35%
Performance Fees 15.00%
ALL TIME HIGH ALL TIME LOW
PRICE: 298.2 PRICE: 86.4
DATE: 12-Feb-21 DATE: 08-Feb-16

Innovation

The AtonRâ Innovation is a long-only, USD-based actively-managed certificate.
From July the 7th 2020 onwards, AtonRâ Innovation invests exclusively its proceeds in the "The AtonRâ Fund" Z-class (no fees).
The AtonRâ Fund invests in long-only listed equities benefiting from secular growth opportunities over a medium to long-term time horizon, with a focus on the technology, healthcare, and renewable energy sectors.
Through one single product, investors gather exposure to the company’s core growth themes which are managed individually since 2014.
The Fund builds on AtonRâ Partners’ unique research and investment approach, which draws scientific, technological, and industrial research together with quality-oriented financial analysis.

Monthly Returns $

(Net of fees)

* Estimated
* Actual

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC ANNUAL
2024 -7.3% 7.7% 3.5% -6.5% -3.4%
2023 11.1% -3.4% 1.9% -2.9% 2.6% 4.1% 3.9% -10.9% -8.4% -9.4% 16.5% 11.4% 13.2%
2022 -17.1% -0.5% 1.2% -17.7% -5.2% -6.3% 9.9% -2.0% -10.9% 4.2% 1.1% -3.5% -40.5%
2021 1.6% -2.6% -4.8% 3.8% -2.4% 9.2% -2.2% 4.1% -5.1% 6.4% -6.6% -5.4% -5.4%
2020 0.5% -3.5% -13.2% 15.5% 11.0% 3.5% 6.6% 5.0% -0.4% -1.8% 13.6% 5.5% 46.7%
2019 12.3% 4.4% -0.4% -0.3% -5.1% 7.8% 1.6% -4.9% -2.3% 1.9% 1.4% 1.3% 17.7%
2018 13.1% -3.1% -4.6% -5.8% 7.9% -3.8% 1.9% 9.4% -0.5% -18.1% 1.8% -11.1% -15.8%
2017 3.7% 6.2% 5.1% 0.1% 6.6% -1.2% 6.5% 3.4% 1.7% 5.8% -0.2% -3.6% 39.1%
2016 -9.0% -3.1% 7.6% -0.0% 9.3% -2.9% 9.9% 2.9% 3.9% -3.8% 3.3% 2.2% 20.0%
2015 -0.0% -0.2% -2.4% 8.5% 2.9% -0.0% 8.7%
Industry Exposure

Top 3 Holdings
  • COINBASE GLOBAL INC
  • MICROSTRATEGY INC
  • BLOCK INC
Top 3 Contributors
  • TRANSMEDICS GROUP
  • INSPIRE MEDICAL
  • CNANO TECHNOLOGY
Worst 3 Contributors
  • MICROSTRATEGY INC
  • COINBASE GLOBAL INC
  • ADYEN
Geographical
Breakdown
Currency
Exposure
Asset
Allocation
Equity Market Cap
Distribution
Equity
Liquidity*

*On average 3 Months daily trading volume

Risk
Scale

5


The actual risk can vary significantly if you cash in at an early stage and you may get back less. You may not be able to sell your product easily or you may have to sell at a price that significantly impacts on how much you get back

Industry Exposure